SANOFI

Sanofi India Share Price

 
Stock touched ten year low

 

Invest in Sanofi India with 3.77X leverage

Invest with MTF
Sanofi India live price: ₹3501.3. It opened at ₹3,591 vs previous close ₹3,595; intraday high/low: ₹3,603/₹3,495. The 50 & 200 DMA stand at ₹3,993.86/₹4,706.25.

Sanofi India Performance

  • Low
  • ₹3,495
  • High
  • ₹3,603
  • 52 Week Low
  • ₹3,495
  • 52 Week High
  • ₹6,717
  • Open Price₹3,591
  • Previous Close₹3,595
  • Volume19,500
  • 50 DMA₹3,993.86
  • 100 DMA₹4,243.04
  • 200 DMA₹4,706.25

Investment Returns

  • Over 1 Month -13.27%
  • Over 3 Month -17.46%
  • Over 6 Month -30.9%
  • Over 1 Year -37.33%

Smart Investing Starts Here Start SIP with Sanofi India for Steady Growth!

Invest Now

Sanofi India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.7
  • PEG Ratio
  • -1.2
  • Market Cap Cr
  • 8,064
  • P/B Ratio
  • 10.5
  • Average True Range
  • 83.13
  • EPS
  • 150.44
  • Dividend Yield
  • 5.5
  • MACD Signal
  • -80.9
  • RSI
  • 18.53
  • MFI
  • 12.23

Sanofi India Financials

Sanofi India Technicals

EMA & SMA

Current Price
₹3,501.30
-93.7 (-2.61%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹3,830.18
  • 50 Day
  • ₹3,993.86
  • 100 Day
  • ₹4,243.04
  • 200 Day
  • ₹4,706.25

Resistance and Support

3533.07 Pivot Speed
  • R3 3,678.43
  • R2 3,640.57
  • R1 3,570.93
  • S1 3,463.43
  • S2 3,425.57
  • S3 3,355.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sanofi India Ltd. is a pharmaceutical company offering a wide range of medicines and vaccines. It focuses on diabetes, cardiovascular, rare diseases, and consumer healthcare, providing solutions to improve health outcomes across India.

Sanofi India Ltd has an operating revenue of Rs. 1,837.40 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of 24% is great, ROE of 43% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 26 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sanofi India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-25 Quarterly Results & Interim Dividend
2025-10-29 Quarterly Results & Interim Dividend
2025-07-31 Quarterly Results
2025-05-14 Quarterly Results
2025-02-27 Audited Results & Final Dividend
Date Purpose Remarks
2025-11-07 INTERIM Rs.75.00 per share(750%)Interim Dividend
2025-04-25 FINAL Rs.117.00 per share(1170%)Final Dividend
2024-05-03 FINAL Rs.117.00 per share(1170%)Final Dividend
2024-03-07 INTERIM Rs.50.00 per share(500%)Interim Dividend
2022-08-08 SPECIAL Rs.193.00 per share (1930%) One Time Special Interim Dividend
View Sanofi India Dividend History Arrow

Sanofi India F&O

Sanofi India Shareholding Pattern

60.4%
9.46%
11.84%
5.55%
0%
10.02%
2.73%

About Sanofi India

  • NSE Symbol
  • SANOFI
  • BSE Symbol
  • 500674
  • Managing Director
  • Mr. Rodolfo Hrosz
  • ISIN
  • INE058A01010

Similar Stocks to Sanofi India

Sanofi India FAQs

Sanofi India share price is ₹3,501 As on 14 March, 2026 | 19:56

The Market Cap of Sanofi India is ₹8063.7 Cr As on 14 March, 2026 | 19:56

The P/E ratio of Sanofi India is 24.7 As on 14 March, 2026 | 19:56

The PB ratio of Sanofi India is 10.5 As on 14 March, 2026 | 19:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23